OTCMKTS:CPMD CannaPharmaRX (CPMD) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free CPMD Stock Alerts $0.01 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.01▼$0.0150-Day Range$0.00▼$0.0252-Week Range$0.00▼$0.03VolumeN/AAverage Volume552,869 shsMarket Capitalization$6.61 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get CannaPharmaRX alerts: Email Address Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About CannaPharmaRX Stock (OTCMKTS:CPMD)CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.Read More CPMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPMD Stock News HeadlinesMarch 14, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannapharmaRx Receives First Purchase Order and Begins Shipment of ProductMarch 12, 2024 | finanznachrichten.deCannaPharmaRx, Inc.: CannaPharmaRx Completes First HarvestsApril 28, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.March 7, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx to Hold Investor Conference CallMarch 5, 2024 | msn.comCannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin AmericaMarch 5, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin AmericasFebruary 23, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue AccelerationFebruary 16, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with CantekApril 28, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.February 16, 2024 | finance.yahoo.comCannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with CantekFebruary 15, 2024 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx CEO Provides Annual Update MessageFebruary 15, 2024 | stockhouse.comCannaPharmaRx CEO Provides Annual Update MessageSeptember 10, 2023 | finance.yahoo.comCannaPharmaRX, Inc. (CPMD) Stock Historical Prices & Data - Yahoo FinanceAugust 25, 2023 | finanznachrichten.deCannapharmarx, Inc.: CannaPharmaRx Expands Board of DirectorsAugust 25, 2023 | finance.yahoo.comCannaPharmaRx Expands Board of DirectorsJune 23, 2023 | finance.yahoo.comCannaPharmaRx Appoints Dean Medwid as New CEOApril 19, 2023 | finance.yahoo.comCannaPharmaRx Signs Agreement with Nasha GeneticsApril 4, 2023 | uk.finance.yahoo.comCannaPharmaRX, Inc. (CPMD) stock historical prices & data – Yahoo FinanceMarch 30, 2023 | finance.yahoo.comCannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial CannabisMarch 21, 2023 | finance.yahoo.comCannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate WebsiteFebruary 21, 2023 | finance.yahoo.comCannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform CompanyFebruary 1, 2023 | finance.yahoo.comCannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of StockJanuary 30, 2023 | finance.yahoo.comCannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023January 11, 2023 | finance.yahoo.comCannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million ExpectedDecember 22, 2022 | finance.yahoo.comCanadian Cannabis; Down but Far from Out - Growth for 2023 and BeyondDecember 21, 2022 | finance.yahoo.comCannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 MillionDecember 21, 2022 | finance.yahoo.comCannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 MillionSee More Headlines Receive CPMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:CPMD CUSIPN/A CIK1081938 Webwww.cannapharmarx.com Phone(949) 652-6838Fax720-875-1905Employees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,530,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-141.66% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-0.14Miscellaneous Outstanding Shares660,630,000Free Float652,236,000Market Cap$6.61 million OptionableNot Optionable Beta2.12 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Dominick Colvin (Age 55)President & Director Comp: $94.65kMr. Dean P. Medwid (Age 56)Chief Executive Officer Mr. Oliver W. Foeste C.A. (Age 48)CPA, Chief Financial Officer Key CompetitorsiBioNYSE:IBIOEnveric BiosciencesNASDAQ:ENVBAzitraNYSEAMERICAN:AZTRShuttle PharmaceuticalsNASDAQ:SHPHIntegrated BioPharmaOTCMKTS:INBPView All Competitors CPMD Stock Analysis - Frequently Asked Questions How have CPMD shares performed in 2024? CannaPharmaRX's stock was trading at $0.0017 on January 1st, 2024. Since then, CPMD stock has increased by 488.2% and is now trading at $0.01. View the best growth stocks for 2024 here. Are investors shorting CannaPharmaRX? CannaPharmaRX saw a decrease in short interest in April. As of April 15th, there was short interest totaling 1,000 shares, a decrease of 47.4% from the March 31st total of 1,900 shares. Based on an average daily trading volume, of 1,927,500 shares, the days-to-cover ratio is currently 0.0 days. View CannaPharmaRX's Short Interest. What other stocks do shareholders of CannaPharmaRX own? Based on aggregate information from My MarketBeat watchlists, some companies that other CannaPharmaRX investors own include Curaleaf (CURLF), Aimmune Therapeutics (AIMT), Refined Metals (CADMF), KushCo (KSHB), Dynavax Technologies (DVAX), GW Pharmaceuticals (GWPH), Organigram (OGI) and AIM ImmunoTech (AIM). How do I buy shares of CannaPharmaRX? Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CPMD) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
